期刊文献+

运脾通络方联合辛伐他汀片治疗非酒精性脂肪性肝炎60例 被引量:1

下载PDF
导出
摘要 目的:观察运脾通络法联合辛伐他汀片治疗非酒精性脂肪肝炎的临床疗效。方法:选择开封市传染病医院感染科收治的非酒精性脂肪肝炎120例,按1∶1的比例分为两组。对照组60例给予辛伐他汀片,1 d 10 mg,随晚餐服用;治疗组60例在对照组治疗基础上采用运脾通络方(苍术、山楂、大黄、姜半夏、菜菔子、泽泻、车前子、决明子、柴胡、甘草片)加减治疗,1 d 1剂,1 d 3次,水煎服。两组均以2个月为1个疗程,共治疗3个疗程后判定疗效。结果:治疗后,治疗组在改善症状、体征、肝脏B超分级、血脂水平方面优于对照组(P<0.01)。结论:运脾通络方联合辛伐他汀片治疗非酒精性脂肪性肝可改善临床症状,降低病情发展等级,改善血脂水平。
作者 谢鸣剑
出处 《中医研究》 2018年第6期33-35,共3页 Traditional Chinese Medicinal Research
  • 相关文献

参考文献5

二级参考文献35

  • 1Chalasani N,Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcohohc fatty hver disease: practice Guideline by the American Association for the Study of Liver Diseases,American College of Gastroenterology, and the American Gastroenterological Association. Hepatology,2012,55:2005-2023.
  • 2Nancy K, Amol S, Thomas RR. Bedside ultrasound in the diagnosis of nonalcohohc fatty liver disease. World J Gastroenterol,2014,20(22): 6821-6825.
  • 3Riley TR, Bruno MA. Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty hver disease versus other chronic hver diseases. J Clin Ultrasound,2005,33(9):439-441.
  • 4Riley TR,Mendoza A,Bruno MA. Bedside ultrasound can predict nonalcoholic fatty liver disease in the hands of clinicians using a prototype image. Dig Dis Sci,2006,51(5):982-985.
  • 5Maki T,Etsuko H,Satoru Y,et al.Imaging of Nonalcoholic Steatohepatitis: Advantages and Pitfalls of Ultrasonography and Computed Tomography. Inter,2009,48:739-746.
  • 6Sasso M,Tengher-bama I,Ziol M,et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan validation in chronic hepatitis C .J Viral Hepat,2012,19(4): 244 -253.
  • 7Bedogni G,Bellentani S,Miglioli L,et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol,2006,6:33.
  • 8Lee JH,Kim D, Kim HJ,et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis, 2010,42(7):503-508.
  • 9Bantel H,Bahr MJ,Schulze OK.An apoptosis biomarker for prediction of nonalcoholic steatohepatitis.Hepatology,2009,50(3):991.
  • 10Moffad P,Contos MJ,Haque M,et al.Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology,2003,37 (6):1286-1292.

共引文献16

同被引文献19

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部